Astrana Health (Astrana Health) ROCE % : 3.20% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Astrana Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Astrana Health's annualized ROCE % for the quarter that ended in Dec. 2023 was 3.20%.

Astrana Health ROCE % Historical Data

The historical data trend for Astrana Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astrana Health ROCE % Chart

Astrana Health Annual Data

Trend

Jan14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

5.75

1.72

11.43

12.04

13.83

Astrana Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															6.49	11.03	16.83	19.53	3.20

Astrana Health ROCE % Calculation

Astrana Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	105.94	/	( ( (966.213 - 148.61)	+	(933.361 - 218.674) )	/ 2 )
	=	105.94	/	( (817.603	+	714.687)	/ 2 )
	=	105.94	/	766.145
	=	13.83 %

Astrana Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	25.384	/	( ( (1073.261 - 202.957)	+	(933.361 - 218.674) )	/ 2 )
	=	25.384	/	( ( 870.304	+	714.687 )	/ 2 )
	=	25.384	/	792.4955
	=	3.20 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Astrana Health (NAS:ASTH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Astrana Health ROCE % Related Terms

Thank you for viewing the detailed overview of Astrana Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Astrana Health (Astrana Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Astrana Health Inc (NAS:ASTH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

3AM:Germany

Address

1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801

Website

https://www.apollomed.net

Apollo Medical Holdings Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care in a cost-effective manner. It is focused on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

Executives

Chandan Basho	officer: See Remarks	1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
John Vong	officer: SVP-Chief Accounting Officer	4288 BIRCHWOOD AVENUE, SEAL BEACH CA 90740
Linda Marsh	director	100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Allied Physicians Of California, A Profession Medical Corp	10 percent owner	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Weili Dai,	director	1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
J. Lorraine Estradas	director	1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
David Schmidt	director	700 N. BRAND BLVD, SUITE 220, GLENDALE CA 91203
Albert Waichow Young	officer: Chief Administrative Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Adrian Vazquez	officer: Chief Medical Officer	C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Thomas S. Lam	director, officer: President and Co-CEO	1668 GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Kenneth T. Sim	director, officer: Executive Chairman and Co-CEO	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Brandon Sim	director, officer: See Remarks	C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801
Eric Chin	officer: Chief Financial Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Michael F. Eng	director	712 BATAAN PLACE, MONTEREY PARK CA 91755
Hing Ang	officer: Chief Operating Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801